Written question asked by Lord Kamall (Conservative) on Monday, 7 September 2026, in the House of Lords. It was due for an answer on Monday, 21 September 2026. It was answered by Baroness Merron (Labour) on Tuesday, 22 September 2026 on behalf of the Department of Health and Social Care.
Propranolol
- Question
-
To ask His Majesty's Government whether the forthcoming mental health strategy for England will address the safety of medicines with psychiatric risk profiles when prescribed for physical health indications; and how the strategy's alignment with the suicide prevention strategy for England will reflect the findings of the Health Services Safety Investigation Body's investigation into the risk of harm from propranolol.
- Answer
-
The Government is developing a new cross-Government mental health strategy for England, to be published later this year. The detailed content of the mental health strategy is still being developed.
Secondary information
- Type
- Written question
- Reference
- HL3187
- Session
- 2026-27
- Subjects
- Mental health services Side effects Suicide Propranolol
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2026-09-22 16:23:11 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL3187
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL3187
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2026-27/HL3187